Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $24.8 Million - $33.5 Million
-68,900 Reduced 31.11%
152,600 $57.9 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $54.1 Million - $65 Million
129,300 Added 140.24%
221,500 $106 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $18.5 Million - $24 Million
-52,600 Reduced 36.33%
92,200 $38.8 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $59.7 Million - $81.6 Million
144,800 New
144,800 $60.4 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.